Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TCR-CD3 complex is a critical multi-subunit signaling apparatus located on the surface of T lymphocytes, essential for the adaptive immune response. It consists of the antigen-binding T-cell receptor (TCR) heterodimer associated with four invariant CD3 chains: the CD3 gamma-epsilon and CD3 delta-epsilon heterodimers, and the CD3 zeta-zeta homodimer (StatPearls, NBK554481). While the TCR recognizes specific peptide-MHC complexes, the CD3 delta, gamma, and zeta chains are responsible for transmitting the activation signal into the cell via their cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) (UniProt, P20963; UniProt, P04234). The CD3 zeta chain, in particular, is a primary driver of signal amplification and is frequently utilized as the signaling domain in Chimeric Antigen Receptor (CAR) T-cell therapies (PubMed, 29983348). This complex is a major therapeutic target for bispecific antibodies that redirect T-cell killing toward tumor cells and for monoclonal antibodies designed to induce immune tolerance in autoimmune conditions like Type 1 diabetes (PubMed, 33033267). Genetic mutations in the CD3 delta, gamma, or zeta subunits can lead to severe combined immunodeficiency (SCID) due to the failure of T-cell maturation and signaling (NCBI Gene, 915).
T-cell activation via ITAM phosphorylation, redirection of T-cell cytotoxicity through bispecific engagement, and immunomodulation via TCR-CD3 complex internalization or T-cell depletion.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor-CD3 complex (CD3 delta, gamma, and zeta subunits) (TCR-CD3 complex).